Yeast Electroporation Protocol for Large Antibody Libraries
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for transforming yeast cells to produce recombinant products and libraries are laborious and inefficient, resulting in smaller library sizes compared to phage display technologies, limiting the effectiveness of yeast display technology for antibody discovery.
Innovation Solution
A highly efficient electroporation protocol using lithium acetate, dithiothreitol, sorbitol, and calcium chloride to transform yeast cells, achieving transformation efficiencies of up to 2 × 10^10 cells, allowing for the construction of large antibody libraries similar in size to those produced by phage display.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional transformation methods are used, then the process is simpler, but transformation efficiency is low resulting in smaller library sizes
Solution Approach 1:
The protocol performs preliminary actions by treating yeast cells with lithium acetate and dithiothreitol before electroporation to enhance cell wall permeability and DNA uptake capability. This pre-treatment prepares the cells in advance to receive DNA more efficiently during the subsequent electroporation step, thereby increasing transformation efficiency without requiring complex equipment changes.
Solution Approach 2:
The protocol optimizes multiple parameters including electroporation voltage (2.5-12.5 kV/cm), DNA concentration, cell density, and buffer composition (sorbitol, calcium chloride). By systematically adjusting these parameters, the protocol achieves transformation efficiencies up to 2 × 10^10 while maintaining a manageable procedural framework that balances complexity with performance.
2Quantity of substance
If yeast display is used for antibody discovery, then eukaryotic expression advantages are gained, but library sizes are limited compared to phage display
Solution Approach 1:
The protocol enables mass production of transformed yeast cells by optimizing the transformation process to generate large numbers of viable transformants. This allows yeast display libraries to reach sizes comparable to phage display libraries (up to 2 × 10^10 transformants), providing sufficient diversity for effective antibody discovery while maintaining the advantages of eukaryotic expression.
3Productivity
If electroporation voltage is increased, then transformation efficiency improves, but cell damage increases
Solution Approach 1:
The protocol applies electroporation voltage at optimized levels (2.5-12.5 kV/cm) that provide sufficient energy to create transient pores in the cell membrane for DNA uptake, while avoiding excessive voltage that would cause permanent cell damage. This partial action approach achieves effective transformation without over-treating the cells, maintaining cell viability.
Solution Approach 2:
The protocol uses sorbitol and calcium chloride in the electroporation buffer to cushion and protect yeast cells during the electroporation process. These agents help stabilize cell walls and membranes, reducing mechanical stress and preventing excessive damage from the electric field, thereby preserving cell viability while still achieving high transformation efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The protocol enables the rapid generation of large yeast libraries, overcoming the limitations of previous methods and enabling the exploration of a much larger antibody diversity space, with demonstrated productivity by identifying human antibodies to TNF-α and IL-18 with low nanomolar affinities.
Implementation Method 1
The invention provides highly efficient and rapid methods of transforming yeast cells by electroporation
Implementation Method 2
Multiple components and conditions including the use of CaCl2, MgCl2, sucrose, sorbitol, lithium acetate, dithiothreitol, electroporation voltage, DNA input, and cell volume were tested or titrated to identify the best combination
Data Source
Figure 1~2
Figure 3A~3B
Figure 4A~4C
AI summary
This invention is directed to the transformation of yeast, and mutants thereof, by electroporation, which result in stably transformed yeast host cells that express recombinant products. This invention also is directed to transformed yeast cells and libraries.